The Cutting Edge Foundation funds surgical procedures and surgical research dedicated to advancing the art of surgery for the purpose of finding actual cures for chronic diseases. The focus of our funding efforts is to support the innovations of the Department of Surgery, University of Illinois at Chicago (UIC) in developing minimally invasive, highly precise robotic surgical techniques to treat some of the most challenging and life-threatening diseases, and in finding functional cures of chronic medical conditions. Our goal is to support these efforts and to make these advanced techniques available to those in need of such medical care, including patients with limited financial means.
"Thank you for supporting our efforts to provide cutting edge treatments for our patients." - Enrico Benedetti, MD, FACS Professor and Head, Department of Surgery University of Illinois at Chicago
Professor and Head, Department of Surgery, Director, Transplant Center, University of Illinois at Chicago. Enrico Benedetti, MD, FACS is currently the Head of the Department of Surgery at the University of Illinois at Chicago. As Chief Division of Transplantation from 1999-2007, Dr. Benedetti established his team as global leaders in state-of-the-art kidney, liver, kidney-pancreas, isolated pancreas, islet cell and small bowel transplantation services. His career-spanning more than two decades-has focused on abdominal organ living donor transplantation. An active member of The Transplantation Society, American Society of Transplant Surgeons, National Kidney Foundation of Illinois and a fellow of the American College of Surgeons, Dr. Benedetti has written more than 200 scientific publications and was the recipient of the 1998 Young Investigator Award from the American Society of Transplant Physicians. He received his medical degree from the University of Florence (Italy) College of Medicine. He completed his residency at University of Illinois Medical Center at Chicago. His pioneering work in living donor intestinal and liver transplantation for children less than five years of age has saved the lives of children with no hope of survival with standard treatments.